We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
2051
Diversified Healthcare Trust
DHC
$2B
| $507K | ﹤0.01% |
166,215
+93,421
| +128% | +$237K |
|
2052
Lemonade
LMND
$4.07B
| $506K | ﹤0.01% |
30,687
-19,564
| -39% | -$326K |
|
2053
Broadstone Net Lease
BNL
$3.99B
| $505K | ﹤0.01% |
31,825
-15,993
| -33% | -$242K |
|
2054
Unifirst Corp
UNF
$5.27B
| $504K | ﹤0.01% |
2,937
+1,365
| +87% | +$220K |
|
|
MRUS
2055
DELISTED
Merus
MRUS
| $501K | ﹤0.01% |
8,470
-332
| -4% | -$16.1K |
|
2056
Essential Properties Realty Trust
EPRT
$6.56B
| $500K | ﹤0.01% |
18,047
+6,519
| +57% | +$174K |
|
2057
Vitesse Energy
VTS
$689M
| $499K | ﹤0.01% |
21,054
-22,247
| -51% | -$529K |
|
2058
Revolution Medicines
RVMD
$44.2B
| $498K | ﹤0.01% |
+12,832
| New | +$480K |
|
2059
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$9.22B
| $495K | ﹤0.01% |
18,529
+9,427
| +104% | +$247K |
|
2060
UFP Technologies
UFPT
$2.5B
| $494K | ﹤0.01% |
1,872
-371
| -17% | -$91.7K |
|
2061
Cadre Holdings
CDRE
$1.44B
| $492K | ﹤0.01% |
14,663
-1,183
| -7% | -$39K |
|
|
RNAM
2062
DELISTED
Avidity Biosciences
RNAM
| $492K | ﹤0.01% |
+12,042
| New | +$346K |
|
2063
Vericel Corp
VCEL
$2.32B
| $491K | ﹤0.01% |
10,701
-5,367
| -33% | -$253K |
|
2064
Glaukos
GKOS
$10.8B
| $490K | ﹤0.01% |
4,141
+211
| +5% | +$22.4K |
|
2065
Expro Ltd
XPRO
$2.05B
| $489K | ﹤0.01% |
+21,347
| New | +$442K |
|
|
FL
2066
DELISTED
Foot Locker
FL
| $489K | ﹤0.01% |
19,928
-43,017
| -68% | -$1.02M |
|
2067
Invesco S&P MidCap Low Volatility ETF
XMLV
$742M
| $489K | ﹤0.01% |
8,853
| – | – |
|
2068
VanEck Semiconductor ETF
SMH
$70.3B
| $488K | ﹤0.01% |
+1,872
| New | +$439K |
|
2069
Sabesp
SBS
$17.7B
| $486K | ﹤0.01% |
186,465
+1,284
| +0.7% | +$3.76K |
|
2070
Summit Therapeutics
SMMT
$11.8B
| $484K | ﹤0.01% |
+62,114
| New | +$335K |
|
2071
Douglas Emmett
DEI
$1.92B
| $479K | ﹤0.01% |
36,432
+1,377
| +4% | +$18.7K |
|
2072
Utah Medical Products
UTMD
$229M
| $478K | ﹤0.01% |
+7,151
| New | +$487K |
|
2073
Glacier Bancorp
GBCI
$6.38B
| $476K | ﹤0.01% |
13,007
+1,627
| +14% | +$60.5K |
|
2074
Alta Equipment Group
ALTG
$251M
| $474K | ﹤0.01% |
58,919
+41,558
| +239% | +$421K |
|
|
NVRO
2075
DELISTED
NEVRO CORP.
NVRO
| $470K | ﹤0.01% |
+55,840
| New | +$595K |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.